An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
Abstract Medulloblastoma (MB) is a pediatric tumor of the cerebellum divided into four groups. Group 3 is of bad prognosis and remains poorly characterized. While the current treatment involving surgery, radiotherapy, and chemotherapy often fails, no alternative therapy is yet available. Few recurre...
Main Authors: | Morgane Morabito, Magalie Larcher, Florence MG Cavalli, Chloé Foray, Antoine Forget, Liliana Mirabal‐Ortega, Mamy Andrianteranagna, Sabine Druillennec, Alexandra Garancher, Julien Masliah‐Planchon, Sophie Leboucher, Abel Debalkew, Alessandro Raso, Olivier Delattre, Stéphanie Puget, François Doz, Michael D Taylor, Olivier Ayrault, Franck Bourdeaut, Alain Eychène, Celio Pouponnot |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-08-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201809830 |
Similar Items
-
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors
by: Oddrun Elise Olsen, et al.
Published: (2020-03-01) -
Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts
by: Thanh-Diep Ly, et al.
Published: (2020-04-01) -
Activin A Modulates Betaglycan Shedding via the ALK4-SMAD3-Dependent Pathway in Endometriotic Cells
by: Agnes N. Mwaura, et al.
Published: (2022-11-01) -
<i>TGFBR1</i> Variants Can Associate with Non-Syndromic Congenital Heart Disease without Aortopathy
by: Manal Alaamery, et al.
Published: (2023-11-01) -
Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
by: T Mahdloo, et al.
Published: (2023-04-01)